ABVC BioPharma, Inc. (ABVC) vs Atossa Therapeutics, Inc. (ATOS)
A side-by-side comparison of ABVC BioPharma, Inc. and Atossa Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABVC
ABVC BioPharma, Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
ATOS
Atossa Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ABVC vs ATOS
growth of $100 · dividends reinvested · last 10yABVC -99.7% (-44.6%/yr)ATOS -99.3% (-39.4%/yr)ATOS compounded faster over this window
ABVC ATOS
ABVC vs ATOS: by the numbers
- •ATOS is the larger company ($25M vs $25M market cap).
Metrics side by side
Valuation
| Metric | ABVC | ATOS |
|---|---|---|
| P/B ratio | 2.44 | 0.94 |
Profitability
| Metric | ABVC | ATOS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.82% | -140.55% |
| ROIC | -53.34% | -146.30% |
Growth (annualized)
| Metric | ABVC | ATOS |
|---|---|---|
| Total return CAGR (5Y) | -46.33% | -44.50% |
Frequently asked
- How have ABVC and ATOS total returns compared?
- Over the past 10 years, ABVC delivered -44.60% and ATOS delivered -39.47% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.